Dräger increases net sales and EBIT

Corporate news announcement processed and transmitted by Hugin AS.
The issuer is solely responsible for the content of this
announcement.
----------------------------------------------------------------------
--------------

* Net sales up 4.3 percent
* EBIT before non-recurring expenses up 13.1 percent
* Growth strongest in Europe and Asia/Pacific
* Forecast for 2008 confirmed

Lübeck, Germany - In the first nine months of 2009, Drägerwerk AG &
Co. KGaA has increased its net sales by 4.3 percent to
EUR 1,307.4 million, primarily thanks to robust growth of 7.5 percent
in the safety division. What is more, EBIT before non-recurring
expenses grew by 13.1 percent to EUR 79.5 million. At
EUR 1,398.3 million, order intake almost matched the prior-year
figure.

The greatest net sales growth was recorded in Germany (up 11.2
percent to EUR 282.3 million), the rest of Europe (up 7.5 percent to
EUR 553.1 million) and the Asia/Pacific region (up 7.4 percent to EUR
150.0 million). As announced for fiscal year 2008, the Dräger Group
posted non-recurring expenses of EUR 20.9 million for personnel and
IT restructuring in the first nine months of 2008. As performance was
in line with expectations up to the end of September, the Company is
confirming its forecast for 2008: with net sales increasing slightly
against the prior year (2007: EUR 1,819 million), the Company expects
EBIT before non-recurring expenses to remain stable. However, the
rapidly deteriorating economic environment could put a dent in
earnings. The Executive Board will monitor developments in the coming
weeks and assess whether or not the forecast can be retained.

Medical division
In the first nine months of 2008, medical increased its order intake
by 2.4 percent to EUR 907.8 million, primarily due to a major order
from South America in the first quarter of 2008. A 2.2 percent
increase in net sales (net of currency effects: 5.3 percent) to
EUR 835.7 million is chiefly attributable to rising demand for
accessories and consumables and architectural systems. EBIT before
non-recurring expenses increased by 15.8 percent to EUR 48.4 million
(prior year: EUR 41.8 million). This is due mainly to the weaker US
dollar which the medical division has benefited from in the first
three quarters as it has manufacturing and development operations in
the US.

Safety division
The safety division's order intake stood at of EUR 509.2 million in
the first three quarters. Adjusted for the impact of two deep-sea
diving projects worth a total of EUR 49.5 million in the third
quarter of 2007, order intake rose by 3.3 percent (net of currency
effects: 6.3 percent). Net sales rose by 7.5 percent (net of currency
effects: 10.5 percent) to EUR 490.5 million. EBIT before
non-recurring expenses amounted to EUR 43.8 million in the reporting
period, up 4.8 percent year on year, despite the dip in safety's
earnings caused by the weak US dollar.

Q1Q1-Q3 2008 key figures for the Group (EUR million)

+-------------------------------------------------------------------+
| | Q3 | Q3 | Q1-Q3 | Q1-Q3 | Change |
| | 2008 | 2007 | 2008 | 2007 | |
|----------------------+-------+-------+---------+---------+--------|
| Order intake | 443.8 | 495.4 | 1,398.3 | 1,410.1 | -0.8% |
|----------------------+-------+-------+---------+---------+--------|
| Medical | 284.8 | 295.1 | 907.8 | 886.1 | +2.4% |
|----------------------+-------+-------+---------+---------+--------|
| Safety | 166.0 | 206.8 | 509.2 | 542.6 | -6.2% |
|----------------------+-------+-------+---------+---------+--------|
| | | | | | |
|----------------------+-------+-------+---------+---------+--------|
| Net sales | 443.9 | 416.1 | 1,307.4 | 1,253.5 | +4.3% |
|----------------------+-------+-------+---------+---------+--------|
| Medical | 284.5 | 273.0 | 835.7 | 817.4 | +2.2% |
|----------------------+-------+-------+---------+---------+--------|
| Safety | 166.1 | 150.2 | 490.5 | 456.2 | +7.5% |
|----------------------+-------+-------+---------+---------+--------|
| | | | | | |
|----------------------+-------+-------+---------+---------+--------|
| EBIT[1] | | | | | |
| before non-recurring | | | | | |
| expenses | 20.6 | 19.4 | 79.5 | 70.3 | +13.1% |
|----------------------+-------+-------+---------+---------+--------|
| Medical | 12.4 | 12.9 | 48.4 | 41.8 | +15.8% |
|----------------------+-------+-------+---------+---------+--------|
| Safety | 14.3 | 13.8 | 43.8 | 41.8 | +4.8% |
|----------------------+-------+-------+---------+---------+--------|
| | | | | | |
|----------------------+-------+-------+---------+---------+--------|
| EBIT margin | 4.6% | 4.7% | 6.1% | 5.6% | |
|----------------------+-------+-------+---------+---------+--------|
| | | | | | |
|----------------------+-------+-------+---------+---------+--------|
| Non-recurring | | | 20.9 | 0.0 | |
| expenses | 9.6 | 0.0 | | | |
|----------------------+-------+-------+---------+---------+--------|
| Medical | 6.7 | 0.0 | 9.3 | 0.0 | |
|----------------------+-------+-------+---------+---------+--------|
| Safety | 0.9 | 0.0 | 6.5 | 0.0 | |
|----------------------+-------+-------+---------+---------+--------|
| | | | | | |
|----------------------+-------+-------+---------+---------+--------|
| Net profit | 1.8 | 5.6 | 22.5 | 27.8 | -19.1% |
|----------------------+-------+-------+---------+---------+--------|
| Earnings per limited | | | | | |
| preferred share (in | | | 1.26 | 1.69 | |
| EUR) | 0.05 | 0.32 | | | -25.4% |
+-------------------------------------------------------------------+

[1] EBIT = Earnings before net interest result and income taxes

Disclaimer
This press release contains forward-looking statements regarding the
future development of the Dräger Group. These forward-looking
statements are based on the current expectations, presumptions, and
forecasts of the Executive Board as well as the information available
to it to date and have been prepared to the best of its knowledge and
belief. No guarantee or liability for the occurrence of the future
developments and results specified can be assumed in respect of such
forward-looking statements. Rather, the future developments and
results are dependent on a number of factors. They entail risks and
uncertainties beyond our control and are based on assumptions which
could prove to be incorrect. Notwithstanding any legal requirements
to adjust forecasts, we assume no obligation to update the
forward-looking statements contained in this report. You will find
all key financial dates on our website at www.draeger.com under
Investor Center/Financial Calendar.

Contact

Corporate Communications:
Burkard Dillig
Tel. +49 451 882-2185
burkard.dillig@draeger.com

Investor Relations:
Vanina Herbst
Tel. +49 451 882-2685
vanina.herbst@draeger.com

Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck, Germany
www.draeger.com

The press release can be downloaded from the following link:

--- End of Message ---

Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55 Lübeck Germany

WKN:
555063; ISIN: DE0005550636; Index: TecDAX, CDAX, HDAX, MIDCAP, Prime
All Share, TECH All Share;
Listed: Geregelter Markt in Börse Berlin, Geregelter Markt in Börse
Düsseldorf,
Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in
Frankfurter Wertpapierbörse,
Geregelter Markt in Hanseatische Wertpapierbörse zu Hamburg,
Geregelter Markt in Niedersächsische Börse zu Hannover,
Geregelter Markt in Bayerische Börse München, Freiverkehr in Börse
Stuttgart;
Copyright © Hugin AS 2008. All rights reserved.